Carcinomatous meningitis as first sign of relapse in a patient with gastric Adenocarcinoma: A rare presentation

Gelijkaardige items

• Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck
  door: Ammar Sukari, et al.
  Gepubliceerd in: (2015-04-01)
• Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy
  door: Juan A. Marín-Jiménez, et al.
  Gepubliceerd in: (2022-07-01)
• Paclitaxel Plus Cetuximab as 1st Line Chemotherapy in Platinum-Based Chemoradiotherapy-Refractory Patients With Squamous Cell Carcinoma of the Head and Neck
  door: Tomohiro Enokida, et al.
  Gepubliceerd in: (2018-08-01)
• The efficacy and safety of tislelizumab combined with weekly nab-paclitaxel, carboplatin, and cetuximab as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a real-world study
  door: Zhanyong Ouyang, et al.
  Gepubliceerd in: (2026-01-01)
• Study to evaluate the acute toxicities and response to concurrent chemoradiotherapy with weekly cisplatin versus cisplatin and paclitaxel in locally advanced head-and-neck cancer
  door: Tony Jacob, et al.
  Gepubliceerd in: (2023-01-01)